Net sales grew year-over-year, led by Life Science and semiconductor-related products, but operating profit declined due to higher raw material and fuel costs. FY2026 guidance projects higher sales but lower profits, with continued dividend growth and major investments in advanced materials.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.